| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 1371938 | Bioorganic & Medicinal Chemistry Letters | 2010 | 5 Pages |
Abstract
New adjuvants of warfarin anticoagulant activity have been developed. These compounds, which are 1,4-methano-1,2,3,4-tetrahydroanthracene-9,10-diol derivatives, act synergistically with warfarin to potentiate its anticoagulant effect. None of the compounds tested is an effective oral anticoagulant in the absence of warfarin.
Graphical abstractFigure optionsDownload full-size imageDownload as PowerPoint slide
Related Topics
Physical Sciences and Engineering
Chemistry
Organic Chemistry
Authors
Jeremiah J. Stromich, Ashley K. Weber, Yousef R. Mirzaei, Michael D. Caldwell, David E. Lewis,